Stryker to announce financial results for its fourth quarter and full year 2025
Rhea-AI Summary
Stryker (NYSE:SYK) will report fourth quarter and full year 2025 financial results on Thursday, January 29, 2026. A press release with summary financial information for the period ended December 31, 2025 will be issued at approximately 4:05 p.m. ET and posted to the company's press releases page.
Stryker will host a live webcast at 4:30 p.m. ET on January 29, 2026 to discuss results; the webcast is accessible on the company's Events & Presentations page and an archive will be available about two hours after the call ends.
Positive
- None.
Negative
- None.
News Market Reaction – SYK
On the day this news was published, SYK gained 0.18%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SYK is down 0.94% with peers mixed: BSX (-1.06%), EW (-0.15%), ABT (-0.41%) softer, while MDT and ZBH are roughly flat, pointing to a stock‑specific tilt rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 11 | Dividend increase | Positive | -0.2% | Announced higher quarterly dividend with a 4.8% year-over-year increase. |
| Dec 04 | Leadership changes | Positive | -0.4% | Named new President and COO plus Orthopaedics leader via internal promotions. |
| Oct 30 | Q3 2025 earnings | Positive | -3.5% | Reported strong Q3 growth, margin expansion, and raised full‑year guidance. |
| Oct 14 | Product portfolio | Positive | +1.4% | Showcased expanded trauma solutions and systems at an orthopaedic meeting. |
| Oct 01 | Earnings date set | Neutral | -1.5% | Scheduled Q3 2025 earnings release and webcast timing details. |
Recent history shows several positive fundamental or shareholder‑friendly announcements coinciding with mild to moderate share price declines, suggesting a tendency for the stock to sell off on good news.
Over the past few months, Stryker announced a $0.88 quarterly dividend with a 4.8% increase, internal leadership promotions effective January 1, 2026, and strong Q3 2025 results with raised full‑year guidance. It also highlighted trauma portfolio expansions at a major orthopaedic meeting and previously scheduled its Q3 earnings date. Today’s Q4 and full‑year 2025 earnings date notice continues this cadence of regular communications on financial performance and strategic execution.
Market Pulse Summary
This announcement sets the timetable for Stryker’s fourth quarter and full‑year 2025 results on January 29, 2026, including a press release at 4:05 p.m. ET and webcast at 4:30 p.m. ET. In recent quarters, the company reported solid revenue growth, margin expansion, and raised guidance, alongside a 4.8% dividend increase. Investors may focus on whether those trends continue and how leadership transitions and capital allocation plans are reflected in the new figures.
AI-generated analysis. Not financial advice.
Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year that ended December 31, 2025.
Stryker will host a webcast at 4:30 p.m. ET on Thursday, January 29, 2026, to discuss its fourth quarter and full year 2025 results. The webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available on the company's website two hours after the live call ends.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com
FAQ
When will Stryker (SYK) release its Q4 and full year 2025 results?
What time is the Stryker (SYK) earnings webcast for Q4 and full year 2025?
Where can investors find Stryker (SYK) Q4 2025 press release and webcast?
Will Stryker (SYK) provide a replay of the January 29, 2026 webcast?
What period do the January 29, 2026 Stryker (SYK) results cover?
